Finally, given the novelty of our findings no evaluation of ferroportin expression or otherwise has to our knowledge as yet been undertaken in subjects with or samples from patients with PAH nor indeed has any evaluation of CD163. The gene discussed is SLC40A1; the disease is pulmonary arterial hypertension.